Table of Content




1. Executive Summary


2. Global Brain Cancer Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Brain Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Brain Cancer Diagnostic Market by Test Type
3.3.1: Imaging Test
3.3.2: Biopsy
3.3.3: Lumber Puncture
3.3.4: Molecular Testing
3.3.5: Electroencephalography
3.3.6: Others

3.4: Global Brain Cancer Diagnostic Market by Cancer Type
3.4.1: Acoustic Neuroma
3.4.2: Astrocytomas
3.4.3: Glioblastoma Multiforme
3.4.4: Meningiomas
3.4.5: Oligodendroglioma
3.4.6: Others

3.5: Global Brain Cancer Diagnostic Market by Age Group
3.5.1: Children
3.5.2: Adult
3.5.3: Geriatic

3.6: Global Brain Cancer Diagnostic Market by End Use
3.6.1: Hospitals
3.6.2: Specialty Clinics
3.6.3: Diagnostic Centers & Research Institutes
3.6.4: Ambulatory Surgical Centers
3.6.5: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Brain Cancer Diagnostic Market by Region
4.2: North American Brain Cancer Diagnostic Market
4.2.2: North American Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others


4.3: European Brain Cancer Diagnostic Market
4.3.1: European Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
4.3.2: European Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others


4.4: APAC Brain Cancer Diagnostic Market
4.4.1: APAC Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
4.4.2: APAC Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others


4.5: ROW Brain Cancer Diagnostic Market
4.5.1: ROW Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
4.5.2: ROW Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Test Type
6.1.2: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Cancer Type
6.1.3: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Age Group
6.1.4: Growth Opportunities for the Global Brain Cancer Diagnostic Market by End Use
6.1.5: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Region

6.2: Emerging Trends in the Global Brain Cancer Diagnostic Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Brain Cancer Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Cancer Diagnostic Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Thermo Fisher Scientific
7.2: Siemens Healthcare Diagnostics
7.3: Hologic
7.4: NantOmics
7.5: GE Healthcare
7.6: NIHON KOHDEN
7.7: Canon
7.8: FUJIFILM Holdings